HOME >> BIOLOGY >> NEWS
Tiny molecules have big potential as cancer drugs, Stanford researcher believes

PHILADELPHIA Many cancer therapies take a "big stick" approach, targeting rapidly dividing cells in the body to stop malignancies in their tracks but often triggering horrible side effects in the process. New research from the Stanford University School of Medicine points toward the possibility of a different type of cancer drug small molecules that would home in on the proteins tumors need without poisoning patients.

Matthew Bogyo, PhD, assistant professor of pathology, will discuss his studies of some of these molecules at an Aug. 24 talk during the "Genomic Approaches to Enzymology" session of the American Chemical Society's national meeting in Philadelphia.

Previous studies have shown that an increase of certain proteins, called cathepsin cysteine proteases, is associated with tumor development. "People have shown that more of the cathepsins are present in cancers and that they appear to be secreted by cancer cells," said Bogyo. "The question is what are they doing and does it help to block them?" To find out, Bogyo and colleagues used fluorescent tags to track cathepsin activity in mouse models of two types of cancer. They found the cathepsins helped build blood vessels to the tumors as well as increase tumor growth and invasiveness.

The team also tried giving a broad-spectrum cathepsin inhibitor to some cancerous mice and found that it slowed tumor development both in early and late stages of growth with no apparent side effects. The National Cancer Institute has since fast-tracked the inhibitor into studies of toxicity and pharmacodynamics as a potential drug. Meanwhile the research group has used the compound as a jumping-off point, testing similar compounds to find those that bind specifically to "problem" cathepsins, instead of to all of them. Bogyo is also looking for additional molecules that have better potency and pharmacodynamic properties.

Bogyo will give details on tests of some of these molecules at his presentatio
'"/>

Contact: Mitzi Baker
mitzibaker@stanford.edu
650-725-2106
Stanford University Medical Center
24-Aug-2004


Page: 1 2

Related biology news :

1. Synthesized molecules studied as weapon to stop cell division in cancer cells
2. Scientists reinvent DNA as template to produce organic molecules
3. Sweet success in targeting sugar molecules to cells in living animals
4. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
5. Scientists pinpoint molecules that generate synapses
6. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
7. Controlling biomolecules with magnetic tweezers
8. Water molecules clump more loosely than previously thought
9. Creating polymers that act like biomolecules
10. A new way to see DNA (and other tiny molecules)
11. St. Jude shows how disorderliness in some proteins lets them interact with a diversity of molecules

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... (PRWEB) , ... May 16, 2019 , ... SFC ... as part of the Industry Development and Discovery Partnership that was awarded to SFC ... of a single integrated pod artificial pancreas (AP) system for people with type 1 ...
(Date:5/14/2019)... ... May 14, 2019 , ... IMMUNE 3D®, ... beyond immuno-oncology into areas of autoimmunity, fibrosis and skin immunology. In addition, the ... lines for IO discovery efforts. , IMMUNE 3D®’s proprietary platform aims to ...
(Date:5/14/2019)... ... 13, 2019 , ... NRD, LLC is excited to announce ... 15-16, 2019, the largest medical technology event in the Northeast serving over 3,300+ ... product organizations. , They will be displaying their latest technologies, including a “sneak ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ALISO VIEJO, Calif. (PRWEB) , ... May 02, ... ... a leading clinical genetics testing company, will present results documenting discrepancies between U.S. ... medical management guidelines for patients at risk for hereditary breast and ovarian cancer ...
(Date:4/16/2019)... ... April 16, 2019 , ... On April ... partner, the U.S. Army Center for Environmental Health Research (USACEHR), with an award ... , Blue Sources, a veteran-owned company located at the Frederick Innovative Technology Center, ...
(Date:4/10/2019)... , ... April 10, 2019 , ... After more than ... The new kitchen is equipped with updated appliances and modern lighting and fixtures, ... Jolla-based venue. , “We’ve seen tremendous growth in the demand for our ...
(Date:4/8/2019)... ... April 08, 2019 , ... US Capital Global Securities , ... preferred equity investment in the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 ... targeted at female hypoactive sexual dysfunction disorder and is ready to begin phase 2b ...
Breaking Biology Technology:
Cached News: